%0 Journal Article
%A Platen, Moritz
%A Flessa, Steffen
%A Teipel, Stefan
%A Rädke, Anika
%A Scharf, Annelie
%A Mohr, Wiebke
%A Buchholz, Maresa
%A Hoffmann, Wolfgang
%A Michalowsky, Bernhard
%T Impact of low-value medications on quality of life, hospitalization and costs - A longitudinal analysis of patients living with dementia.
%J Alzheimer's and dementia
%V 19
%N 10
%@ 1552-5260
%C Hoboken, NJ
%I Wiley
%M DZNE-2023-00670
%P 4520 - 4531
%D 2023
%X This study aimed to analyze the impact of low-value medications (Lvm), that is, medications unlikely to benefit patients but to cause harm, on patient-centered outcomes over 24 months.This longitudinal analysis was based on baseline, 12 and 24 months follow-up data of 352 patients with dementia. The impact of Lvm on health-related quality of life (HRQoL), hospitalizations, and health care costs were assessed using multiple panel-specific regression models.Over 24 months, 182 patients (52
%K Humans
%K Quality of Life
%K Health Care Costs
%K Hospitalization
%K Dementia: drug therapy
%K Alzheimer's disease (Other)
%K dementia (Other)
%K health care costs (Other)
%K health care resources (Other)
%K health-related quality of life (Other)
%K hospitalization (Other)
%K low-value care (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:36905286
%R 10.1002/alz.13012
%U https://pub.dzne.de/record/258697